Brief: Forte Biosciences Announces The FDA Has Granted Fast Track Designation To FB-401 For The Treatment Of Atopic Dermatitis
26/10/2020 12:31
Oct 26 (Reuters) - Forte Biosciences Inc FBRX.O :
* FORTE BIOSCIENCES, INC. ANNOUNCES THE FDA HAS GRANTED FAST
TRACK
DESIGNATION TO FB-401 FOR THE TREATMENT OF ATOPIC DERMATITIS
* FORTE BIOSCIENCES, INC. ANNOUNCES THE FDA HAS GRANTED FAST
TRACK
DESIGNATION TO FB-401 FOR THE TREATMENT OF ATOPIC DERMATITIS
Source text for Eikon: ID:nBw14tfrPa
Further company coverage: FBRX.O
((Reuters.Briefs@thomsonreuters.com;))